Literature DB >> 16132678

Immunogenicity of cholera toxin B epitope inserted in Salmonella flagellin expressed on bacteria and administered as DNA vaccine.

Neeraj Chauhan1, Ravindra Kumar, Jitendra Badhai, Anju Preet, Pramod Kumar Yadava.   

Abstract

Salmonella vaccine strains have been previously reported to evoke immune response against heterologous antigen cloned in the flagellin gene. A non-toxic cholera toxin subunit B epitope was selected by using computer-based program and genetically fused in single and double copy in Salmonella typhimurium flagellin gene. The chimeric flagellin functioned normally as demonstrated by motility assay. Cholera toxin B epitope cloned in flagellin was expressed at the flagellar surface. The expression was verified by Western blotting. Mice administered orally and subcutaneously with aroA flagellin-negative strain of S. dublin expressing the chimeric flagellin gene resulted in generation of antibody against cholera toxin. Mice administered intramuscularly and subcutaneously with naked mammalian expression vector containing the same cholera toxin epitope could also evoke the antibody response though it was less than the chimeric flagellin. (Mol Cell Biochem 276: 1-6, 2005).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16132678     DOI: 10.1007/s11010-005-2240-z

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  26 in total

Review 1.  Selective delivery of antigens by recombinant bacteria.

Authors:  R Curtiss; S M Kelly; P A Gulig; K Nakayama
Journal:  Curr Top Microbiol Immunol       Date:  1989       Impact factor: 4.291

Review 2.  Modern vaccines. Progress towards vaccines we need and do not have.

Authors:  A Robbins
Journal:  Lancet       Date:  1990-06-16       Impact factor: 79.321

3.  Role of different lymphoid tissues in the initiation and maintenance of DNA-raised antibody responses to the influenza virus H1 glycoprotein.

Authors:  C M Boyle; M Morin; R G Webster; H L Robinson
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  A simple method for displaying the hydropathic character of a protein.

Authors:  J Kyte; R F Doolittle
Journal:  J Mol Biol       Date:  1982-05-05       Impact factor: 5.469

6.  Antibodies against synthetic peptides of the B subunit of cholera toxin: crossreaction and neutralization of the toxin.

Authors:  C O Jacob; M Sela; R Arnon
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

7.  Construction, expression, and immunogenicity of the Schistosoma mansoni P28 glutathione S-transferase as a genetic fusion to tetanus toxin fragment C in a live Aro attenuated vaccine strain of Salmonella.

Authors:  C M Khan; B Villarreal-Ramos; R J Pierce; G Riveau; R Demarco de Hormaeche; H McNeill; T Ali; N Fairweather; S Chatfield; A Capron
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

8.  Construction of a potential bivalent vaccine strain: introduction of Shigella sonnei form I antigen genes into the galE Salmonella typhi Ty21a typhoid vaccine strain.

Authors:  S B Formal; L S Baron; D J Kopecko; O Washington; C Powell; C A Life
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

9.  Salmonella typhimurium aroA mutants as carriers of the Escherichia coli heat-labile enterotoxin B subunit to the murine secretory and systemic immune systems.

Authors:  D J Maskell; K J Sweeney; D O'Callaghan; C E Hormaeche; F Y Liew; G Dougan
Journal:  Microb Pathog       Date:  1987-03       Impact factor: 3.738

10.  Oral immunization of mice with attenuated Salmonella enteritidis containing a recombinant plasmid which codes for production of the B subunit of heat-labile Escherichia coli enterotoxin.

Authors:  J D Clements; F L Lyon; K L Lowe; A L Farrand; S el-Morshidy
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

View more
  6 in total

Review 1.  Flagellin as an adjuvant: cellular mechanisms and potential.

Authors:  Steven B Mizel; John T Bates
Journal:  J Immunol       Date:  2010-11-15       Impact factor: 5.422

Review 2.  Flagellin a toll-like receptor 5 agonist as an adjuvant in chicken vaccines.

Authors:  Shishir Kumar Gupta; Preety Bajwa; Rajib Deb; Madhan Mohan Chellappa; Sohini Dey
Journal:  Clin Vaccine Immunol       Date:  2014-01-22

3.  Chimeric flagellin expressed by Salmonella typhimurium induces an ESAT-6-specific Th1-type immune response and CTL effects following intranasal immunization.

Authors:  Hui Zhang; Liu Liu; Ke Wen; Jinlin Huang; Shizhong Geng; Junsong Shen; Zhiming Pan; Xinan Jiao
Journal:  Cell Mol Immunol       Date:  2011-08-15       Impact factor: 11.530

Review 4.  An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives.

Authors:  Alessio Facciolà; Giuseppa Visalli; Antonio Laganà; Angela Di Pietro
Journal:  Vaccines (Basel)       Date:  2022-05-22

5.  Escherichia coli K88ac fimbriae expressing heat-labile and heat-stable (STa) toxin epitopes elicit antibodies that neutralize cholera toxin and STa toxin and inhibit adherence of K88ac fimbrial E. coli.

Authors:  Chengxian Zhang; Weiping Zhang
Journal:  Clin Vaccine Immunol       Date:  2010-10-27

6.  Crystal structure of Bacillus cereus flagellin and structure-guided fusion-protein designs.

Authors:  Meong Il Kim; Choongdeok Lee; Jaewan Park; Bo-Young Jeon; Minsun Hong
Journal:  Sci Rep       Date:  2018-04-11       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.